Dr. Reddys Laboratories Receives USFDA Tentative Approval for Zenavod(TM) (doxycycline) Capsules, 40 mg for the Treatment of Rosacea in Adults
HYDERABAD, India & PRINCETON, N.J.--(Healthcare Sales & Marketing Network)--Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announced today the U.S. Food and Drug Administration (US FDA) tentative approval for Zenavod (doxycycline) Capsul... Biopharmaceuticals, Dermatology, FDADr. Reddy's Laboratories, Zenavod, doxycycline, rosacea
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Dermatology | Doxycycline | Food and Drug Administration (FDA) | Marketing | Pharmaceuticals | Rosacea | Skin